Mangoceuticals Common Stock Forecast - Naive Prediction
| MGRX Stock | 0.51 0.03 5.56% |
The Naive Prediction forecasted value of Mangoceuticals Common Stock on the next trading day is expected to be 0.57 with a mean absolute deviation of 0.12 and the sum of the absolute errors of 7.42. Mangoceuticals Stock Forecast is based on your current time horizon.
At this time the relative strength index (rsi) of Mangoceuticals Common's share price is below 20 . This indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Quarterly Revenue Growth (0.37) |
Using Mangoceuticals Common hype-based prediction, you can estimate the value of Mangoceuticals Common Stock from the perspective of Mangoceuticals Common response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Mangoceuticals Common Stock on the next trading day is expected to be 0.57 with a mean absolute deviation of 0.12 and the sum of the absolute errors of 7.42. Mangoceuticals Common after-hype prediction price | USD 0.51 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Mangoceuticals | Build AI portfolio with Mangoceuticals Stock |
Mangoceuticals Common Additional Predictive Modules
Most predictive techniques to examine Mangoceuticals price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Mangoceuticals using various technical indicators. When you analyze Mangoceuticals charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Mangoceuticals Common's financial statements to predict how it will affect future prices.
Cash | First Reported 2010-12-31 | Previous Quarter 67.5 K | Current Value 64.1 K | Quarterly Volatility 226.7 K |
Mangoceuticals Common Naive Prediction Price Forecast For the 25th of January
Given 90 days horizon, the Naive Prediction forecasted value of Mangoceuticals Common Stock on the next trading day is expected to be 0.57 with a mean absolute deviation of 0.12, mean absolute percentage error of 0.02, and the sum of the absolute errors of 7.42.Please note that although there have been many attempts to predict Mangoceuticals Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Mangoceuticals Common's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Mangoceuticals Common Stock Forecast Pattern
| Backtest Mangoceuticals Common | Mangoceuticals Common Price Prediction | Buy or Sell Advice |
Mangoceuticals Common Forecasted Value
In the context of forecasting Mangoceuticals Common's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Mangoceuticals Common's downside and upside margins for the forecasting period are 0.01 and 11.45, respectively. We have considered Mangoceuticals Common's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Mangoceuticals Common stock data series using in forecasting. Note that when a statistical model is used to represent Mangoceuticals Common stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 116.2042 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.1197 |
| MAPE | Mean absolute percentage error | 0.1129 |
| SAE | Sum of the absolute errors | 7.4196 |
Predictive Modules for Mangoceuticals Common
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Mangoceuticals Common. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Mangoceuticals Common After-Hype Price Prediction Density Analysis
As far as predicting the price of Mangoceuticals Common at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Mangoceuticals Common or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Mangoceuticals Common, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Mangoceuticals Common Estimiated After-Hype Price Volatility
In the context of predicting Mangoceuticals Common's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Mangoceuticals Common's historical news coverage. Mangoceuticals Common's after-hype downside and upside margins for the prediction period are 0.03 and 11.39, respectively. We have considered Mangoceuticals Common's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Mangoceuticals Common is out of control at this time. Analysis and calculation of next after-hype price of Mangoceuticals Common is based on 3 months time horizon.
Mangoceuticals Common Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Mangoceuticals Common is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Mangoceuticals Common backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Mangoceuticals Common, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.65 | 10.88 | 0.30 | 0.05 | 16 Events / Month | 7 Events / Month | In about 16 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.51 | 0.51 | 0.00 |
|
Mangoceuticals Common Hype Timeline
Mangoceuticals Common is now traded for 0.51. The entity has historical hype elasticity of -0.3, and average elasticity to hype of competition of 0.05. Mangoceuticals is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is now at -1.65%. %. The volatility of related hype on Mangoceuticals Common is about 38857.14%, with the expected price after the next announcement by competition of 0.56. The company has price-to-book ratio of 0.56. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Mangoceuticals Common recorded a loss per share of 2.72. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 16th of October 2024. Given the investment horizon of 90 days the next projected press release will be in about 16 days. Check out Historical Fundamental Analysis of Mangoceuticals Common to cross-verify your projections.Mangoceuticals Common Related Hype Analysis
Having access to credible news sources related to Mangoceuticals Common's direct competition is more important than ever and may enhance your ability to predict Mangoceuticals Common's future price movements. Getting to know how Mangoceuticals Common's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Mangoceuticals Common may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| VSEE | VSee Health | (0.03) | 10 per month | 7.37 | 0.04 | 13.51 | (12.24) | 120.19 | |
| FEMY | Femasys | (0.01) | 17 per month | 6.83 | 0.04 | 15.00 | (11.11) | 47.42 | |
| CASI | CASI Pharmaceuticals | (0.02) | 10 per month | 0.00 | (0.16) | 5.88 | (7.69) | 32.11 | |
| ENTO | Entero Therapeutics | (0.17) | 10 per month | 7.81 | 0.08 | 16.50 | (17.06) | 56.75 | |
| HCTI | Healthcare Triangle | 0.05 | 32 per month | 0.00 | (0.37) | 9.51 | (16.15) | 45.77 | |
| CLSD | Clearside Biomedical | 0.15 | 2 per month | 0.00 | (0.27) | 7.96 | (17.54) | 83.67 | |
| TOI | Oncology Institute | (0.12) | 9 per month | 0.00 | (0.05) | 6.53 | (8.31) | 42.16 | |
| PALI | Palisade Bio | 0.19 | 5 per month | 6.66 | 0.03 | 13.86 | (10.26) | 31.35 | |
| ASBP | Aspire BioPharma | 0.20 | 4 per month | 0.00 | (0.21) | 19.52 | (23.85) | 63.79 | |
| CING | Cingulate | 0.04 | 8 per month | 4.51 | 0.09 | 7.46 | (6.75) | 20.19 |
Other Forecasting Options for Mangoceuticals Common
For every potential investor in Mangoceuticals, whether a beginner or expert, Mangoceuticals Common's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Mangoceuticals Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Mangoceuticals. Basic forecasting techniques help filter out the noise by identifying Mangoceuticals Common's price trends.Mangoceuticals Common Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Mangoceuticals Common stock to make a market-neutral strategy. Peer analysis of Mangoceuticals Common could also be used in its relative valuation, which is a method of valuing Mangoceuticals Common by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Mangoceuticals Common Market Strength Events
Market strength indicators help investors to evaluate how Mangoceuticals Common stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Mangoceuticals Common shares will generate the highest return on investment. By undertsting and applying Mangoceuticals Common stock market strength indicators, traders can identify Mangoceuticals Common Stock entry and exit signals to maximize returns.
| Accumulation Distribution | 24058.42 | |||
| Daily Balance Of Power | (0.50) | |||
| Rate Of Daily Change | 0.94 | |||
| Day Median Price | 0.54 | |||
| Day Typical Price | 0.53 | |||
| Price Action Indicator | (0.04) | |||
| Period Momentum Indicator | (0.03) |
Mangoceuticals Common Risk Indicators
The analysis of Mangoceuticals Common's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Mangoceuticals Common's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting mangoceuticals stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 7.25 | |||
| Standard Deviation | 10.77 | |||
| Variance | 115.95 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Mangoceuticals Common
The number of cover stories for Mangoceuticals Common depends on current market conditions and Mangoceuticals Common's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Mangoceuticals Common is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Mangoceuticals Common's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Mangoceuticals Common Short Properties
Mangoceuticals Common's future price predictability will typically decrease when Mangoceuticals Common's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Mangoceuticals Common Stock often depends not only on the future outlook of the potential Mangoceuticals Common's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Mangoceuticals Common's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2 M | |
| Cash And Short Term Investments | 58.7 K |
Additional Tools for Mangoceuticals Stock Analysis
When running Mangoceuticals Common's price analysis, check to measure Mangoceuticals Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mangoceuticals Common is operating at the current time. Most of Mangoceuticals Common's value examination focuses on studying past and present price action to predict the probability of Mangoceuticals Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mangoceuticals Common's price. Additionally, you may evaluate how the addition of Mangoceuticals Common to your portfolios can decrease your overall portfolio volatility.